Welcome to our dedicated page for Gbt Technologies news (Ticker: GTCH), a resource for investors and traders seeking the latest updates and insights on Gbt Technologies stock.
GBT Technologies Inc. reports developments in artificial intelligence, Internet of Things and intelligent platform technologies through its OTC Pink-traded public-company updates. Recent company news centers on wholly owned subsidiaries that extend its platform into automated wellness retail and digital media.
Recurring themes include Cube Wellness Technologies, which deploys AI-enabled smart wellness machines for university, workplace and community environments, and Cube X Media Corporation, which creates digital advertising, vertical video and cinematic content for distribution across interactive machine networks. Updates also cover subsidiary formation, leadership and board appointments, material agreements, capital-structure matters and operating results.
GBT Technologies Inc. (OTC PINK: GTCH) aims to develop its xCalibre imaging system for post-processed medical imaging analysis. This innovative technology utilizes advanced algorithms to detect abnormalities in various imaging modalities like CT, X-RAY, MRI, and Ultrasound, thereby assisting medical professionals in diagnostics. The company seeks to enhance diagnostic accuracy through its patented image recognition technology, although it acknowledges the need for substantial capital and strategic partnerships for successful implementation and regulatory approval.
GBT Technologies Inc. (OTC PINK: GTCH) is embarking on the development of a radio-based patient health monitoring system under the project name “Apollo.” The technology aims to provide a non-invasive way to monitor vital signs, sleep patterns, and even detect emergencies using AI algorithms to analyze radio wave reflections. The system is designed to cater to individuals who prefer not to wear devices, offering a comprehensive monitoring solution for home or facility use. However, success depends on raising capital and forming strategic partnerships for manufacturing and distribution.
GBT Technologies (OTC PINK: GTCH) has submitted a registration application to the System for Award Management (SAM) to facilitate business dealings with U.S. government agencies. This registration is crucial for bidding on federal contracts and receiving federal funds. GBT aims to leverage its expertise in AI, IoT, and other technologies to provide solutions in military, security, and emergency services. The company envisions becoming a significant provider of advanced technology within the government sector, contributing to national security and economic growth.
GBT Technologies (OTC PINK: GTCH) announced the completion of its Gen II qTerm device, featuring enhancements for improved measurement accuracy and user compatibility. The upgraded device measures body temperature, blood oxygen, and heart rate with increased stability. An advanced coprocessor chip has been added for better performance. Currently undergoing technical testing, the Gen II device aims for FDA certification to be classified as a medical device for telemedicine use. The company plans to raise capital for further development and potential market entry.
GBT Technologies Inc. has initiated PHASE I testing for its Infinia long-range radio communication system, focusing on large metropolitan areas like Los Angeles. The system utilizes high-frequency radio technology to enable audio and data transmission over extensive distances through sky waves. Initial tests indicate successful communication, with future assessments planned to optimize performance. The company emphasizes the need for capital and strategic partnerships for further development, indicating uncertainty in actual implementation.
GBT Technologies Inc. (GTCH) is advancing its xCalibre image analysis technology by integrating it with the Infinia radio system. This combination aims to facilitate real-time image recognition and analysis using CCTV cameras from remote locations worldwide. xCalibre will utilize AI to detect humans and objects, while the Infinia system promises high-speed data transmission with ultra-low latency. However, success relies on securing funding, regulatory approvals, and partnerships. GBT emphasizes the potential for intelligent surveillance but cautions about uncertainties in development.
GBT Technologies Inc. (OTC PINK: GTCH) has filed a patent application with the USPTO for a technology aimed at enhancing the reliability of integrated circuits (ICs). The patent focuses on systems and methods for real-time analysis of microchip designs to identify and rectify reliability issues during the design phase, potentially saving significant engineering time. With advancements targeting manufacturing nodes of 5nm and below, the technology employs AI for rapid data analysis, promising to improve power consumption and overall chip performance. However, successful implementation hinges on securing capital and forming strategic partnerships.
GBT Technologies (GTCH) has defined an HF antenna system for its Infinia long-range radio prototype to ensure reliable communication in challenging environments. The company is assessing the optimal specifications for the antenna, focusing on frequency response and effective aperture to enhance point-to-point communication. This technology aims to serve applications like telemedicine, emergency response, and military communications. However, GBT faces uncertainty regarding the successful development and implementation of this system, requiring additional capital and strategic partnerships.
GBT Technologies Inc. (OTC PINK: GTCH) is advancing its research on a non-invasive external device for arterial and tissue imaging. This unit, intended to operate with a robotic arm, aims to provide detailed 3D images using proprietary radio wave technology as part of the Hermes capsule research project. The system may assist in detecting blockages and identifying foreign objects within the body. However, the successful development of this device hinges on adequate funding, regulatory approvals, and partnerships for manufacturing and distribution.
GBT Technologies (OTC PINK: GTCH) announced its ongoing research into Kirlian Electrophotography, aiming to explore health correlations and applications for its qTerm device. The company utilizes advanced imaging algorithms to analyze Kirlian images for patterns, colors, and shapes, potentially reflective of health conditions. The research seeks to identify early disease symptoms through these unique energy fields emitted by living tissues. However, GBT warns that successful implementation depends on securing capital and developing partnerships, with uncertain outcomes.